Jyothy Labs share news, announcements and annual reports
NSE: JYOTHYLABBSE: 532926Household ProductsSmall Cap
Jyothy Labs Limited · Formerly Jyothy Laboratories · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2007
Last close ₹171.91down ₹3.15 (1.80%)BSE ₹172.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹175.06.
30 Oct: open ₹174.45, high ₹175.10, low ₹171.00
52-week range of traded prices to 30 Oct 2026
₹171.00Low, 30 Oct 2026₹322.75High, 30 Oct 2025
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and buyback. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,313 Cr603rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.23
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.04%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 19.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,85,76453.8% delivered
Jyothy Labs share news and announcements
834 announcements, routine notices left out, newest first. Page 16 of 17.
Jun 2012
15 Jun · Board meeting
13 Jun · Board meeting
Inter alia, to consider following : (1) The proposal of Amalgamation of Henkel India Limited (HIL), with Jyothy Laboratories Limited (JLL); (2) The Scheme of Amalgamation between HIL and JLL; (3) The Valuation report for the purpose of exchange ratio; (4) The Fairness Opinion; (5) Other matters incidental and connected to the said amalgamation between HIL and JLL.
May 2012
23 May · Board meeting
Board of Directors of the Company at its meeting held on May 23, 2012 has : (1) Appointed Mr. S. Raghunandan as Whole-time Director and Chief Executive Officer of the Company with effect from May 23, 2012. (2) Appointed Mr. Ramkrishnan Lakshminarayanan as Additional Director (Independent Director) of the Company with effect from May 23, 2012.23 May · Dividend
Board of Directors of the Company at its meeting held on May 23, 2012 have recommended dividend of Rs.2.50/ (Rupees Two and Paise Fifty Only) per equity shares of Re.1/- each for the financial year ended March 31, 2012. The payment of dividend is subject to approval of shareholders at the ensuing Annual General Meeting.23 May · Corporate action
Board of Directors of the Company at its meeting held on May 23, 2012 declared issue of Bonus Shares, subject to approval of the shareholders in the ensuing Annual General Meeting, in the ratio of 1:1, i.e., issue of 1 (One) Bonus Equity Share for every 1 (One) Equity Share that shall be held by the shareholders as on the Record Date, which will be decided by the Board after conclusion of the ensuing Annual General Meeting. These Bonus Shares shall be entitled to dividend that may be declared for the financial year 2012-13 and thereafter.7 May · Board meeting
To consider inter-alia the following : (a) Results of the Company for the Financial Year ended March 31, 2012; and (b) Declaration of dividend, if any, for the said Financial Year.
Jan 2012
30 Jan · Updates
Company has raised a long term loan of Rs. 430 crores for redemption of existing Redeemable, Zero Coupon Non-Convertible Debentures aggregating to Rs. 460 crores maturing on January 27, 2012.23 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 23, 2012, inter alia, appointed Mr. K. Ullas Kamath, Deputy Managing Director as Joint Managing Director of the Company with effect from January 23, 2012.9 Jan · Board meeting
Inter-alia to consider and take on record the Un-Audited Financial Results of the Company for the 3rd Quarter ended December 31, 2011.
Dec 2011
14 Dec · Disclosure
Nov 2011
Oct 2011
31 Oct · Board meeting
Inter alia to consider the unaudited financial results of the Company for the 2nd quarter and half year ended September 30, 2011 .17 Oct · Business
Jyothy Laboratories Limited ("JLL") informs shareholders that it has acquired a total of 14,035,431 Equity Shares, being 12.05% of the equity share capital of Henkel India Limited ("HIL") through the Open Offer. Pursuant to completion of payment to tendering shareholders, these equity shares have been transferred to Jyothy. Further, 59,360,203 equity shares of HIL, forming 50.97% of its equity share capital, which were acquired from Henkel AG & Co. KGaA in May, 2011, have also been released from an escrow account into JLL's account. As on date, the shareholding of JLL in the equity shares of HIL stands at 83.65%.
Sep 2011
Aug 2011
23 Aug · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from September 10, 2011 to September 20, 2011 (both days inclusive) for the purpose of Annual General Meeting to be held on September 20, 2011 and payment of dividend.12 Aug · Results
2 Aug · Board meeting
Inter-alia to consider the Un-audited Financial Results of the Company for the 1st Quarter ended June 30, 2011.
Jun 2011
May 2011
30 May · Dividend
Board of Directors of the Company at its meeting held on May 30, 2011 have recommended dividend of Rs.5/- per equity shares of Re.1/- each for the financial year ended March 31, 2011. The payment of dividend is subject to approval of shareholders.20 May · Board meeting
To consider inter-alia the following: (a) Results of the Company for the Financial Year ended March 31, 2011; and (b) Declaration of dividend, if any, for the said Financial Year.5 May · Results
We propose to choose option of publishing audited financial results of the company within 60 days of expiry of last quarter of the previous financial year. Therefore, audited financial results for the quarter ended March 31, 2011 and the financial year April 2010/March 2011 will be adopted by the Board of Directors of the Company on or before May 30, 20115 May · News Verification
News Verification : The media had reports that a private equity player may acquire 26% stake in the company. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Jyothy Laboratories Limited has vide its letter inter-alia stated,"We would like to place on records that the company is not in talks with any PE funds to sell 26% stake in the company. We would also like to clarify that select reports appearing in the media for the past few weeks are speculative in nature and we would not like to comment on such rumours and speculations."
Apr 2011
28 Apr · News Verification
News Verification : The media had reports that Jyothy Laboratories Limited may buy 51% stake in Henkel India. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Jyothy Laboratories Limited has vide its letter inter-alia stated," The Company had purchased 14.9% stake in Henkel in March 2011 and following that has also participated in the bid to acquire Henkel AG and Co's 50.97% stake in Henkel India Ltd. However, as of date we are awaiting for the outcome of the bid. We would like to clarify that all reports appearing in the media are speculative in nature. When any such deal is finalised, the stock exchanges will be informed."
Mar 2011
17 Mar · Business
Board of Directors of Jyothy Laboratories Limited("Board") met on March 16, 2011 and considered and approved the acquisition of 1,73,51,686 equity shares of Rs.10/- each (fully paid up) representing 14.90% of the paid up equity share capital of Henkel India Limited ("Shares") from Tamilnadu Petroproducts Limited at a price not exceeding Rs.35/- per equity share of Henkel India Limited.
Feb 2011
24 Feb · Updates
High Court having judicature at Mumbai has passed an Order for amalgamation of Sri Sai Homecare Products Private Limited (Wholly Owned Subsidiary Company) with the Company. The said Order was filed with Registrar of Companies, Maharastra as per compliance of the provisions of the Companies Act, 1956.
Jan 2011
17 Jan · Board meeting
Inter-alia to consider and take on record the Un-Audited Financial Results of the Company for the 3rd Quarter ended December 31, 2010.
Oct 2010
15 Oct · Board meeting
Inter-alia to consider and take on record the Un-audited Financial Results of the Company for the 2nd Quarter / Half year ended September 30, 2010.
Aug 2010
Jul 2010
28 Jul · Meeting
Annual General Meeting(AGM) was held on July 27, 2010 and following is the gist of the resolutions passed / outcome of the above AGM: (1) Annual Report for the Financial Year ended March 31, 2010 were considered and adopted by members of the Company; (2) Payment of dividend @ Rs.4/- per share on 7,25,68,800 Equity Shares, aggregating to Rs.29,02,75,200/- was declared by the Shareholders for the Financial Year ended March 31, 2010; (3) Mr.Nilesh B. Mehta and Ms. M.R. Jyothy, were re-appointed as Directors of the Company, liable to retire by rotation; (4) M/s. S.R. Batliboi & Associates, Chartered Accountants, Mumbai were re-appointed as Auditors of the Company; (5) Register of Members and Copies of Annual Returns of the Company will be kept at the office of Registrars and Share Transfer Agents of the Company, i.e., Link Intime India Private Limited; (6) Ms.M.R. Deepthi was re-appointed as 'Manager-Finance' for a period of 5 (five) years commencing from August 1, 2010 and remuneration payable to her was approved, subject to approval of the Central Government; (7) Mr.Ravi Razdan was appointed as 'Head-I.T.' for period of 5 (five) years commencing from April 1, 2010 and remuneration payable to him was approved, subject to approval of the Central Government.20 Jul · Board meeting
Inter-alia to consider and take on record the Un-audited Financial Results of the Company for the 1st Quarter ended June 30, 2010.
Jun 2010
21 Jun · Business
There were some amendments in the amalgamation process : (1) Effective Date: Effective Date is now 'April 1, 2010' instead of 'April 1, 2009' mentioned earlier. - Certified True Copy of the Resolution passed at the Board Meeting of; (a) Transferee Company held on January 27, 2010, and, (b) Transferor Company held on March 10, 2010. (2) Authorized and Paid-Up Share Capital of the Transferor Company: Authorized and Paid- Up Equity Share Capital of the Company is Rs.2,00,00,000/- divided into 20,00,000 Equity Shares of Rs.10/- each. (3) Registered Office of the Transferor Company: Registered Office of the Transferor Company is now situated in the State of Maharashtra at 'Ujala House', Ram Krishna Mandir Road, Kondivita, Andheri (East), Mumbai - 400059. (4) Amended ?Scheme of Amalgamation? approved at the Board Meeting of Transferor and Transferee Company held on May 25, 2010.21 Jun · Board meeting
Board of Directors of the Company have on June 21, 2010 approved the following business through resolutions passed by circulation : (1) Issue of Equity Shares to Qualified Institutional Buyers (QIB's) through Qualified Institutional Placement (QIP) up to an amount of Rs. 300 Crore; (2) Constitution of Capital Issue Committee for the purpose of (1) above; (3) Amendment to the Notice and Explanatory Statement under Section 173(2) of the Companies Act, 1956, convening Annual General Meeting of the Company (AGM) by inclusion of the above item (1) for the purpose of obtaining approval of the members at the AGM.11 Jun · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from July 17, 2010 to July 27, 2010 (both days inclusive) in connection with the ensuing Annual General Meeting of the Company scheduled to be held on July 27, 2010 as well as payment of dividend.
May 2010
25 May · Dividend
Board of Directors at their meeting held on May 25, 2010 have recommended dividend of Rs.4/- per equity shares of Re.1/- each for the financial year ended March 31, 2010. The payment of dividend is subject to approval of shareholders.